Other languages Celadon Pharmaceuticals Plc

Equities

CEL

GB00BDQYGP38

Market Closed - London S.E. Other stock markets 11:35:06 2024-04-26 am EDT			5-day change	1st Jan Change
102.5 ^GBX	-2.38%		-12.77%	-10.87%

Mar. 08	Celadon hails early results of chronic pain trial	AN
Mar. 07	Celadon Pharmaceuticals plc Announces the Results of an Early Economic Analysis of the Data Collected as Part of the Feasibility Study for Its Fully Approved Chronic Pain Clinical Trial	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Celadon hails early results of chronic pain trial	Mar. 08
Celadon Pharmaceuticals plc Announces the Results of an Early Economic Analysis of the Data Collected as Part of the Feasibility Study for Its Fully Approved Chronic Pain Clinical Trial	Mar. 07
Celadon announces start of cannabis supply for two UK companies	Dec. 14
Celadon Delivers Pharmaceutical-grade Product Under Two Orders; Stock Rises	Dec. 14
Celadon Pharmaceuticals plc Announces the First Supply of Its Pharmaceutical-Grade Product to the Two Commercial Contracts	Dec. 14
Celadon Pharma raises GBP2.0 million via placing	Dec. 12
Celadon Pharmaceuticals Raises GBP2 Million in Share Sale	Dec. 12
Celadon Pharmaceuticals Wins Cannabis Product Supply Deal in Europe; Stock Surges	Nov. 16
Celadon shares rise on supply contract worth up to GBP26 million	Nov. 16
Celadon Pharmaceuticals plc Enters into Contract for the Commercial Supply of Its Pharmaceutical-Grade Cannabis Product with a Leading European Medicinal Cannabis Company	Nov. 16
Celadon Pharmaceuticals raises GBP1.0 million through shares	23-10-13
UK's Celadon Pharmaceuticals Raises GBP1 Million via Share Placing, Subscription	23-10-13
Advanced Medical Solutions appoints non-executive director as chair	23-10-02
Celadon Pharmaceuticals interim loss narrows; optimistic for future	23-09-28
Earnings Flash (CEL.L) CELADON PHARMACEUTICALS Posts H1 Revenue GBP8,000	23-09-28
Celadon Pharmaceuticals Plc Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-28
Celadon Pharmaceuticals Secures New Cannabis Product Deal in UK	23-09-05
Celadon shares rise on second UK contract win for cannabis product	23-09-05
Celadon Pharmaceuticals plc Enters into New Sales Contract with UK Pharmaceutical Company	23-09-05
Celadon receives approval for 5,000 patient clinical cannabis trial	23-08-01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Celadon Pharmaceuticals Plc

Equities

CEL

GB00BDQYGP38

Other languages

Filters